Title: | Prospective study of bipolar disorder and neurodegenerative diseases |
Journal: | npj Parkinson's Disease |
Published: | 3 Oct 2024 |
Pubmed: | https://pubmed.ncbi.nlm.nih.gov/39362870/ |
DOI: | https://doi.org/10.1038/s41531-024-00794-z |
Title: | Prospective study of bipolar disorder and neurodegenerative diseases |
Journal: | npj Parkinson's Disease |
Published: | 3 Oct 2024 |
Pubmed: | https://pubmed.ncbi.nlm.nih.gov/39362870/ |
DOI: | https://doi.org/10.1038/s41531-024-00794-z |
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Bipolar disorder (BD) is linked to an increased risk of neurodegenerative diseases such as dementia and Parkinson disease (PD), yet several uncertainties still remain and the extent to which the associations could be explained by BD-related medications (antipsychotics, lithium, and antiepileptics) was unknown. This study included 501,233 UK Biobank participants (mean [standard deviation] age, 56.5 [8.10] years; 54.4% women), free of dementia and PD at baseline. After a median 13.8 year follow-up, 9422 cases of dementia and 3457 PD cases were identified. Participants with BD had a significantly higher risk of dementia (adjusted hazard ratio [HR] 2.52, 95% CI 2.00-3.19) and PD (adjusted HR 2.88, 95% CI 2.03-4.08). Findings suggest that up to two-thirds of the association of neurodegenerative diseases with BD may be mediated by BD-related medications. Further research is needed to confirm these findings and explore the underlying mechanisms.</p>
Application ID | Title |
---|---|
96083 | Associations of diet and metabolic profile with risk of cardiometabolic disease and neurodegenerative disease |
Enabling scientific discoveries that improve human health